Argenx Se (ARGX) Current Assets (2015 - 2025)
Argenx Se (ARGX) posted Current Assets of $6.9 billion for Q4 2025, down 99.88% on a QoQ basis from $5829.7 billion in Q2 2025, and up 41.29% year-over-year from $4.9 billion in Q4 2024.
Argenx Se (ARGX) Current Assets (2015 - 2025) Analysis & Trends
Argenx Se's Current Assets history runs 11 years deep, the most recent figure standing at $6.9 billion for Q4 2025.
- Quarterly Current Assets rose 41.29% year-over-year to $6.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 billion (up 41.29% YoY) and the FY2025 annual result came in at $6.9 billion, up 41.29% from the prior year.
- Current Assets was $6.9 billion for Q4 2025 at Argenx Se, down from $5829.7 billion in the prior quarter.
- Across five years, Current Assets topped out at $5829.7 billion in Q2 2025 and bottomed at $2.5 billion in Q4 2021.
- A 5-year average of $586.4 billion and a median of $3.5 billion in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets slipped 8.12% — and 2025, when it soared 136626.76%.
- Argenx Se's Current Assets stood at $2.5 billion in 2021, then climbed by 9.09% to $2.8 billion in 2022, then surged by 48.65% to $4.1 billion in 2023, then increased by 18.41% to $4.9 billion in 2024, then jumped by 41.29% to $6.9 billion in 2025.
- Business Quant data shows ARGX's Current Assets at $6.9 billion in Q4 2025, $5829.7 billion in Q2 2025, and $4.9 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 73.04 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.59 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 6.60 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.97 Bn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 4.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.90 Bn |
| Jun 30, 2025 | 5,829.74 Bn |
| Dec 31, 2024 | 4.88 Bn |
| Jun 30, 2024 | 4.26 Bn |
| Dec 31, 2023 | 4.12 Bn |
| Jun 30, 2023 | 2.69 Bn |
| Dec 31, 2022 | 2.77 Bn |
| Jun 30, 2022 | 2.93 Bn |
| Dec 31, 2021 | 2.54 Bn |
| Jun 30, 2021 | 2.86 Bn |
| Dec 31, 2020 | 2.00 Bn |
| Jun 30, 2020 | 2.16 Bn |
| Dec 31, 2019 | 1.52 Bn |
| Jun 30, 2019 | 1.08 Bn |
| Dec 31, 2018 | 653.38 Mn |
| Jun 30, 2018 | 424.58 Mn |
| Dec 31, 2017 | 431.89 Mn |
| Jun 30, 2017 | 200.02 Mn |
| Dec 31, 2016 | 109.91 Mn |
| Dec 31, 2015 | 48.38 Mn |